Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Byetta Pancreatic Cancer

byetta pancreatic cancerSince hitting the market in 2005, the diabetes drug Byetta has been used by millions of patients dealing with type-2 diabetes to control high blood sugar. Briston-Myers Squibb purchased the rights to the drug in 2012 in an effort to increase sales even further.

Unfortunately, health experts with the FDA, University of California at Los Angeles and American Medical Association have advised that diabetes drugs like Byetta may be associated with thyroid cancer and Byetta pancreatic cancer. 

Pancreatic cancer is a severe condition that attacks the lining of the pancreas, an organ that helps metabolize and digest sugars. It can spread quickly and go undetected, which gives those affected a poor prognosis. Because of this, it is a leading cause of cancer death.

Byetta pancreatic cancer may have several common symptoms, including: 

  • Pain in the abdomen or back
  • Loss of appetite
  • Weight loss
  • Jaundice (yellowing of the skin and eyes)
  • Blood clots
  • Depression

You should speak with a doctor immediately if you have noticed any of these symptoms. If your doctor diagnoses pancreatic cancer and you have taken Byetta, you may be eligible to file a defective drug claim that will provide significant help for your condition.

Lawyers are currently helping those affected by Byetta pancreatic cancer file lawsuits against Bristol-Myers Squibb (BMS) based on the company’s failure to properly warn patients of the dangers.

If you or a loved one were diagnosed with pancreatic cancer after taking Byetta, it is important to speak with a lawyer about your legal rights as soon as possible. Contact us today.

The FDA first raised concerns over Byetta pancreatic risks in 2007. Amid significant reports of patients suffering pancreatitis and 6 deaths among users, they issued a public advisory and ordered the maker to add label warnings.

Experts have warned that pancreatitis, or inflammation of the pancreas, increases the risk of pancreatic cancer

In a 2011 study from the University of California at Los Angeles, researchers found that the use of Byetta could increase the risk of pancreatitis by 600% and the risk of Byetta pancreatic cancer by 290%. However, they cautioned that further testing was necessary.

This year, the Journal for the American Medical Association published a new study in February cautioning that diabetes drugs like Byetta could double the risk of pancreatitis, which can lead to pancreatic cancer. The FDA followed this with a new warning in March of 2013.

If you or a family member have been affected by pancreatic cancer, it is important to speak with a lawyer about what help is available and how long you have to take action. It costs nothing to discuss your case or file a claim.

Lawsuits against powerful drug companies for defective drug injuries such as this can be very complex. Therefore, it is important to choose a lawyer with experience in this type of case. DrugRisk only recommends lawyers and law firms that have already handled Byetta lawsuits.

Contact us today for more information on the warnings, research, side effects and legal news related to Byetta and other diabetes drugs, or to speak with a lawyer. We are available 24 hours a day to help.